These target genes and GRIM-19 levels were further confirmed from corresponding xenograft tumor tissues by qRT-PCR (Figure 5C and 5D and Supplementary Figure S4A), which is consistent with the in vitro results. This evidence concerns the gene NDUFA13 and neoplasm.